FindTrial
Sign In

Based on the real world study to discuss the case registration of Yiqiwenyang method in the treatment of myasthenia gravis

Based on the real world study to discuss the case registration of Yiqiwenyang method in the treatment of myasthenia gravis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005715
Enrollment
Unknown
Registered
2022-03-15
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia Gravis

Interventions

control group:western medicine
treatment group 1:western medicine+Chinese herbal medicine
treatment group 2:western medicine+Chinese herbal medicine+acupuncture
treatment group 3:Chinese herbal medicine

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Meet the clinical diagnostic criteria of myasthenia gravis in the 2020 version of the Chinese guidelines; ? Unlimited age and gender; ? The patients or his family members understand the research content and sign the informed consent form.

Exclusion criteria

Exclusion criteria: ? Patients with severe heart, brain, liver, kidney and other diseases in the past; ? Patients with recent myasthenia crisis.

Design outcomes

Primary

MeasureTime frame
Quantitative Myasthenia Gravis Score;—

Secondary

MeasureTime frame
Myasthenia Gravis-Quality of Life-15 Scale;Myasthenia Gravis-Activity of Daily Living Scale ;—

Countries

China

Contacts

Public ContactWenzeng Zhu
zhuwenzeng530@163.com15810195459

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026